ArticleFrontiers in neuroscience2018
Cu
Open access · goldAbstract read
In one paragraph
Article in Frontiers in neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 31 citations in OpenAlex.
- Metallothionein and neurodegenerative diseases.Neural regeneration research · 2026Article
- Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases.MedComm · 2026Review
- Mechanism of Metal Complexes in Alzheimer's Disease.International journal of molecular sciences · 2024Review
- Differential Cytokine Responses of APOE3 and APOE4 Blood-brain Barrier Cell Types to SARS-CoV-2 Spike Proteins.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024Article
- Evidence for disrupted copper availability in human spinal cord supports CuScientific reports · 2024Article
- Microglial ferroptotic stress causes non-cell autonomous neuronal death.Molecular neurodegeneration · 2024Article
- Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.Current medical science · 2024Review
- Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex.International journal of molecular sciences · 2022Article
- Copper Preserves Vasculature Structure and Function by Protecting Endothelial Cells from Apoptosis in Ischemic Myocardium.Journal of cardiovascular translational research · 2021Article
- Microglia and Astrocytes in Alzheimer's Disease in the Context of the Aberrant Copper Homeostasis Hypothesis.Biomolecules · 2021Review
- CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1Scientific reports · 2021Article
- Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer's Disease.International journal of molecular sciences · 2021Article
- Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic.Angewandte Chemie (International ed. in English) · 2021Review
- Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis.Antioxidants & redox signaling · 2021Review
- Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond.Life (Basel, Switzerland) · 2020Review
- Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.International journal of molecular sciences · 2020Review
- The molecular mechanisms of copper metabolism and its roles in human diseases.Pflugers Archiv : European journal of physiology · 2020Review
- Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.Journal of molecular biology · 2019Review
- Alzheimer's Disease Phenotype or Inflammatory Insult Does Not Alter Function of L-Type Amino Acid Transporter 1 in Mouse Blood-Brain Barrier and Primary Astrocytes.Pharmaceutical research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 4 institutions in 2 countries.
Xin Yi ChooDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Jeffrey R LiddellDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Mikko T HuuskonenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Alexandra GrubmanDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Diane MoujalledDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Jessica RobertsDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Kai KyseniusDepartment of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia.
Lauren PattenDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Hazel QuekCell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Lotta E OikariCell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Clare DuncanDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Simon A JamesFlorey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
Lachlan E McInnesSchool of Chemistry, Bio21 Institute for Molecular Science and Biotechnology, The University of Melbourne, Melbourne, VIC, Australia.
David J HayneSchool of Chemistry, Bio21 Institute for Molecular Science and Biotechnology, The University of Melbourne, Melbourne, VIC, Australia.
Paul S DonnellySchool of Chemistry, Bio21 Institute for Molecular Science and Biotechnology, The University of Melbourne, Melbourne, VIC, Australia.
Eveliina PollariA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Suvi VähätaloA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Katarína LejavováA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Mikko I KettunenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Tarja MalmA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Jari KoistinahoA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Anthony R WhiteDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
Katja M KanninenDepartment of Pathology, The University of Melbourne, Melbourne, VIC, Australia.
University of Melbourne · AUUniversity of Eastern Finland · FIFlorey Institute of Neuroscience and Mental Health · AUQIMR Berghofer Medical Research Institute · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
astrocytecopperinflammationmicroglianeurodegeneration
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.